Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Safety of GBL1204—An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study

Saved in:
Bibliographic Details
Published in:Ophthalmology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552785368186881
collection WordPress RSS
FRELIP Feed Integration
container_title Ophthalmology and Therapy
description
discipline_display Ophthalmology and Optometry
discipline_facet Ophthalmology and Optometry
format Online Article
RSS Article
genre Journal Article
id rss_article:60971
institution FRELIP
journal_source_facet Ophthalmology and Therapy
last_indexed 2026-06-20T21:26:07.255Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Safety of GBL1204—An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study
Ophthalmology and Optometry
General
Ophthalmology and Optometry
sub_discipline_display General
sub_discipline_facet General
subject_display Ophthalmology and Optometry
General
Ophthalmology and Optometry
subject_facet Ophthalmology and Optometry
General
Ophthalmology and Optometry
title Safety of GBL1204—An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study
title_alt Seguridad de GBL1204—Un Bevacizumab Oftálmico en Jeringa Precargada para la Degeneración Macular Neovascular Asociada a la Edad: Un Estudio de Fase I
Sécurité du GBL1204 — un bévacizumab ophtalmique en seringue préremplie pour la dégénérescence maculaire néovasculaire liée à l'âge : étude de phase I
Segurança do GBL1204—Um Bevacizumabe Oftálmico em Seringa Pré-Cheia para Degeneração Macular Neovascular Relacionada à Idade: Um Estudo de Fase I
title_auth Safety of GBL1204—An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study
title_es_txt Seguridad de GBL1204—Un Bevacizumab Oftálmico en Jeringa Precargada para la Degeneración Macular Neovascular Asociada a la Edad: Un Estudio de Fase I
title_fr_txt Sécurité du GBL1204 — un bévacizumab ophtalmique en seringue préremplie pour la dégénérescence maculaire néovasculaire liée à l'âge : étude de phase I
title_full Safety of GBL1204—An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study
title_fullStr Safety of GBL1204—An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study
title_full_unstemmed Safety of GBL1204—An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study
title_pt_txt Segurança do GBL1204—Um Bevacizumabe Oftálmico em Seringa Pré-Cheia para Degeneração Macular Neovascular Relacionada à Idade: Um Estudo de Fase I
title_short Safety of GBL1204—An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I Study
title_sort safety of gbl1204—an ophthalmic bevacizumab in prefilled syringe for neovascular age-related macular degeneration: a phase i study
topic Ophthalmology and Optometry
General
Ophthalmology and Optometry
url https://link.springer.com/article/10.1007/s40123-026-01414-0